MedTrace Logo

Transcutaneous Bilirubinometry and Phototherapy

NCT04246229 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2024-08-02

No results posted yet for this study

Summary

A randomized Controlled trial comparing the use of transcutaneous bilirubinometry to serum bilirubin measurements (via blooddraws = standard care) in neonates born after a gestational age \> 32 weeks and \< 15 days of age treated with Phototherapy for neonatal hyperbilrubinemia.

Conditions

  • Neonatal Hyperbilirubinemia

Interventions

DIAGNOSTIC_TEST

Transcutaneous bilirubinometry

use of transcutaneous bilirubinometry a non-invasieve measurement of skin bilirubin levels

DIAGNOSTIC_TEST

Serum bilirubin

use of blood draws to measure serum bilirubin level

Sponsors & Collaborators

  • Princess Amalia Children's Clinic

    lead OTHER

Principal Investigators

  • Jolita Bekhof, MD,PhD · 1971

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
0 Days
Max Age
2 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-12-31
Completion
2027-05-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04246229 on ClinicalTrials.gov